Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Harvard Business School
Express Scripts
McKinsey
Colorcon

Last Updated: August 11, 2022

EPANED Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Epaned patents expire, and when can generic versions of Epaned launch?

Epaned is a drug marketed by Azurity and Silvergate Pharms and is included in two NDAs. There are thirteen patents protecting this drug and one Paragraph IV challenge.

This drug has three patent family members in three countries.

The generic ingredient in EPANED is enalapril maleate. There are twenty-seven drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the enalapril maleate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Epaned

A generic version of EPANED was approved as enalapril maleate by HERITAGE PHARMA on August 22nd, 2000.

  Try it Free

Paragraph IV (Patent) Challenges for EPANED
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
EPANED Oral Solution enalapril maleate 1 mg/mL 208686 1 2018-08-31

US Patents and Regulatory Information for EPANED

EPANED is protected by seventeen US patents.

Patents protecting EPANED

Enalapril formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Enalapril formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF HEART FAILURE

Enalapril formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF TREATMENT OF HEART FAILURE

Enalapril formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF TREATING HYPERTENSION

Enalapril formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF TREATING LEFT VENTRICULAR DYSFUNCTION

Enalapril formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF HYPERTENSION

Enalapril formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Enalapril formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing


Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Enalapril formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Enalapril formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Enalapril formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Enalapril formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF HYPERTENSION

Enalapril formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF TREATING LEFT VENTRICULAR DYSFUNCTION

Enalapril formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF TREATING HYPERTENSION

Enalapril formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF HEART FAILURE

Enalapril formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF TREATMENT OF HEART FAILURE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Azurity EPANED enalapril maleate SOLUTION;ORAL 208686-001 Sep 20, 2016 AB RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Silvergate Pharms EPANED KIT enalapril maleate FOR SOLUTION;ORAL 204308-001 Aug 13, 2013 DISCN Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Azurity EPANED enalapril maleate SOLUTION;ORAL 208686-001 Sep 20, 2016 AB RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Azurity EPANED enalapril maleate SOLUTION;ORAL 208686-001 Sep 20, 2016 AB RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Silvergate Pharms EPANED KIT enalapril maleate FOR SOLUTION;ORAL 204308-001 Aug 13, 2013 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Azurity EPANED enalapril maleate SOLUTION;ORAL 208686-001 Sep 20, 2016 AB RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for EPANED

See the table below for patents covering EPANED around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 3429581 FORMULATIONS D'ÉNALAPRIL (ENALAPRIL FORMULATIONS) See Plans and Pricing
Brazil 112018068960 formulações de enalapril See Plans and Pricing
World Intellectual Property Organization (WIPO) 2017161339 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Boehringer Ingelheim
Dow
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.